Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 81-90 of 304 for heart disease

Edit search filters
  1. ABSORB III Randomized Controlled Trial (RCT)

    Rochester, MN

  2. Cara CDRM (Conduction Disturbance Risk Monitor) 2.0

    Rochester, MN

  3. A Study to Evaluate the Effectiveness and Safety of DA-1229 (Evogliptin) in Delaying Progression of Mild or Moderate Calcific Aortic Stenosis (EVOID-AS trial)

    Jacksonville, FL, Rochester, MN, Scottsdale/Phoenix, AZ

  4. "About Me" Pedigree Tool Pilot

    Rochester, MN

  5. Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol

    Rochester, MN

  6. Function of Artificial Intelligence-enabled Electrocardiogram in Early Detection of Patients With Aortic Stenosis

    Rochester, MN

  7. A Study of Heart and Kidney Protection with Empagliflozin

    Jacksonville, FL

  8. Continued Access to PREVAIL (CAP2)

    Rochester, MN

  9. Stroke Mitigation in A-fib Reasoning Tool for Shared Decision Making

    Rochester, MN

  10. Safety and Efficacy of ANX-042 in Human Cardiorenal Syndrome

    Rochester, MN

.

Mayo Clinic Footer